TUESDAY, 19 SEPTEMBER 2023 - SESSION II: Pathway to Optimizing Submission and Review of CMC Post-Approval Changes: Employing Scientific Risk-Based Principles, Reliance Pathways, Adoption of WHO Post-Approval Guidelines, and Collaborative Assessments
Speakers
DIGEMID-General Directorate of Medicines, Supplies and Drugs
DIGEMID-General Directorate of Medicines, Supplies and Drugs